Effect of oral bacteria on peripheral blood leukocyte interleukin-6 and soluble interleukin-6 receptor production

R A Lindemann1, S A Kinder Haake, M Kjeldsen

  • 1Section of Oral Biology, UCLA School of Dentistry 90095-1668, USA.

Insights

Monocytes release interleukin 6 (IL-6) when exposed to oral pathogens. Soluble IL-6 receptor is constitutively produced by immune cells and may regulate IL-6 activity.

Area of Science:

  • Immunology
  • Oral Microbiology
  • Cell Biology

Background:

  • Interleukin 6 (IL-6) is a key cytokine in inflammation.
  • Soluble IL-6 receptor (sIL-6R) modulates IL-6 activity.
  • Oral pathogenic bacteria are implicated in various inflammatory conditions.

Purpose of the Study:

  • To investigate the impact of specific oral pathogenic bacteria on IL-6 and sIL-6R production by human peripheral blood mononuclear cells (PBMCs).
  • To identify which immune cell subsets within PBMCs are responsible for IL-6 and sIL-6R release upon bacterial stimulation.

Main Methods:

  • Human PBMCs, lymphocytes, T cells, and monocytes were cultured with five oral bacteria: Actinobacillus actinomycetemcomitans, Capnocytophaga gingivalis, Capnocytophaga ochracea, Fusobacterium nucleatum, and Porphyromonas gingivalis.
  • Supernatants were analyzed for IL-6 and sIL-6R concentrations using enzyme-linked immunosorbent assay (ELISA).
  • Cellular responses were assessed after 24-hour incubation periods.

Main Results:

  • Monocytes and PBMCs demonstrated significant IL-6 release when co-cultured with all tested oral bacteria.
  • IL-6 production by peripheral blood lymphocytes was significantly lower compared to monocyte-containing cultures, even with activation.
  • None of the tested oral bacteria elevated soluble IL-6 receptor release above baseline levels.

Conclusions:

  • Monocytes are the primary responders to oral pathogens, releasing IL-6.
  • Soluble IL-6 receptor is constitutively produced by T cells and monocytes.
  • The constitutive production of sIL-6R suggests a role in modulating IL-6 signaling pathways in response to oral bacteria.